Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Riedel

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JCI Insight|October 13, 2022
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cellsHaroon Shaikh, Joern Pezoldt, Zeinab Mokhtari, et al.
Haematologica|February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complexXiang Zhou, Andrej Besse, Jessica Peter, et al.
British Journal of Haematology|May 8, 2024
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker studyXiang Zhou, Vivien Wagner, Lukas Scheller, et al.
Blood|August 22, 2024
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myelomaMara John, Moutaz Helal, Johannes Duell, et al.
Nature Immunology|August 5, 2020
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lungMartijn J Schuijs, Shaun Png, Arianne C Richard, et al.
Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.
Blood Cancer Discovery|November 14, 2025
Composition and functional state of T and NK cells in the extramedullary myeloma tumor microenvironmentAnjana Anilkumar Sithara, Veronika Kapustova, David Zihala, et al.
Immunity|September 16, 2025
A TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancerGreta Mattavelli, Moutaz Helal, Ana Cetkovic, et al.
The Journal of Clinical Investigation|September 24, 2025
USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancerNishi Kumari, Sarah Ce Wright, Christopher M Witham, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JCI Insight|October 13, 2022
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cellsHaroon Shaikh, Joern Pezoldt, Zeinab Mokhtari, et al.
Haematologica|February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complexXiang Zhou, Andrej Besse, Jessica Peter, et al.
British Journal of Haematology|May 8, 2024
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker studyXiang Zhou, Vivien Wagner, Lukas Scheller, et al.
Blood|August 22, 2024
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myelomaMara John, Moutaz Helal, Johannes Duell, et al.
Nature Immunology|August 5, 2020
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lungMartijn J Schuijs, Shaun Png, Arianne C Richard, et al.
Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.
Blood Cancer Discovery|November 14, 2025
Composition and functional state of T and NK cells in the extramedullary myeloma tumor microenvironmentAnjana Anilkumar Sithara, Veronika Kapustova, David Zihala, et al.
Immunity|September 16, 2025
A TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancerGreta Mattavelli, Moutaz Helal, Ana Cetkovic, et al.
The Journal of Clinical Investigation|September 24, 2025
USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancerNishi Kumari, Sarah Ce Wright, Christopher M Witham, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Pageof 4